Skip to main content

Advertisement

SpringerLink
Log in

Racial, ethnic and socioeconomic disparities in the treatment of brain tumors

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Disparities in American health care based on socially-defined patient characteristics such as race, ethnicity, and socioeconomic position are well-documented. We review differences and disparities in incidence, pathobiology, processes and outcomes of care, and survival based on social factors for brain tumors of all histologies. In the US, black patients have lower incidences of most brain tumor types and lower-income patients have lower incidences of low grade glioma, meningioma and acoustic neuroma; ascertainment bias may contribute to these findings. Pathogenetic differences between malignant gliomas in patients of different races have been demonstrated, but their clinical significance is unclear. Patients in disadvantaged groups are less often treated by high-volume providers. Mortality and morbidity of initial treatment are higher for brain tumor patients in disadvantaged groups, and they present with markers of more severe disease. Long term survival differences between malignant glioma patients of different races have not yet been shown. Clinical trial enrollment appears to be lower among brain tumor patients from disadvantaged groups. We propose future research both to better define disparities and to alleviate them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allison JJ, Weissman NW, Silvey AB, Chapin CA, Kiefe CI (2008) Identifying top-performing hospitals by algorithm: results from a demonstration project. Jt Comm J Qual Patient Saf 34:309–317

    PubMed  Google Scholar 

  2. 2007 National Healthcare Quality Report (2008) Agency for Healthcare Research and Quality. U.S. Department of Health and Human Services, Rockville, MD

  3. Institute of Medicine (2001) Crossing the quality chasm: a new health system for the 21st century. National Academies Press, Washington

    Google Scholar 

  4. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA (2003) The quality of health care delivered to adults in the United States. N Engl J Med 348:2635–2645. doi:10.1056/NEJMsa022615

    PubMed  Google Scholar 

  5. Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, McGlynn EA (2006) Who is at greatest risk for receiving poor-quality health care? N Engl J Med 354:1147–1156. doi:10.1056/NEJMsa044464

    PubMed  CAS  Google Scholar 

  6. 2007 National Healthcare Disparities Report (2008) Agency for Healthcare Research and Quality. U.S. Department of Health and Human Services, Rockville, MD

  7. Smedley BD, Stith AY, Nelson AR (eds) (2003) Unequal treatment: confronting racial and ethnic disparities in health care. National Academies Press, Washington

    Google Scholar 

  8. Aspinall PJ (2008) The categorization of African descent populations in Europe and the USA: should lexicons of recommended terminology be evidence-based? Public Health 122:61–69. doi:10.1016/j.puhe.2007.02.018

    PubMed  CAS  Google Scholar 

  9. Braun L, Fausto-Sterling A, Fullwiley D, Hammonds EM, Nelson A, Quivers W, Reverby SM, Shields AE (2007) Racial categories in medical practice: how useful are they? PLoS Med 4:e271. doi:10.1371/journal.pmed.0040271

    PubMed  Google Scholar 

  10. Shields AE, Fortun M, Hammonds EM, King PA, Lerman C, Rapp R, Sullivan PF (2005) The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. Am Psychol 60:77–103. doi:10.1037/0003-066X.60.1.77

    PubMed  Google Scholar 

  11. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dube R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ (1999) The effect of race and sex on physicians’ recommendations for cardiac catheterization. N Engl J Med 340:618–626. doi:10.1056/NEJM199902253400806

    PubMed  CAS  Google Scholar 

  12. Todd KH, Deaton C, D’Adamo AP, Goe L (2000) Ethnicity and analgesic practice. Ann Emerg Med 35:11–16. doi:10.1016/S0196-0644(00)70099-0

    PubMed  CAS  Google Scholar 

  13. Bach PB, Cramer LD, Warren JL, Begg CB (1999) Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198–1205. doi:10.1056/NEJM199910143411606

    PubMed  CAS  Google Scholar 

  14. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM (1999) The effect of patients’ preferences on racial differences in access to renal transplantation. N Engl J Med 341:1661–1669. doi:10.1056/NEJM199911253412206

    PubMed  CAS  Google Scholar 

  15. Ayanian JZ, Weissman JS, Chasan-Taber S, Epstein AM (1999) Quality of care by race and gender for congestive heart failure and pneumonia. Med Care 37:1260–1269. doi:10.1097/00005650-199912000-00009

    PubMed  CAS  Google Scholar 

  16. Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK, Kucken LE, Vladeck BC (1996) Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 335:791–799. doi:10.1056/NEJM199609123351106

    PubMed  CAS  Google Scholar 

  17. Byrd WM, Clayton L (2001) An American health dilemma: a medical history of African-Americans and the problem of race. Routledge, New York

    Google Scholar 

  18. Byrd WM, Clayton L (2002) An American health dilemma: race, medicine and health care in the United States. Routledge, New York

    Google Scholar 

  19. Betancourt JR, Maina AW, Soni SM (2005) The IOM report Unequal Treatment: lessons for clinical practice. Del Med J 77:339–348

    PubMed  Google Scholar 

  20. Haynes MA, Smedley BD (eds) (1999) The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. National Academies Press, Washington

    Google Scholar 

  21. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB (2002) Survival of blacks and whites after a cancer diagnosis. JAMA 287:2106–2113. doi:10.1001/jama.287.16.2106

    PubMed  Google Scholar 

  22. Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S, Yin X (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 113:582–591. doi:10.1002/cncr.23567

    PubMed  Google Scholar 

  23. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP (2005) Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds. Br J Cancer 92:241–245

    PubMed  CAS  Google Scholar 

  24. Thuppal S, Propp JM, McCarthy BJ (2006) Average years of potential life lost in those who have died from brain and CNS tumors in the USA. Neuroepidemiology 27:22–27. doi:10.1159/000093896

    PubMed  Google Scholar 

  25. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722–4729. doi:10.1200/JCO.2007.12.2440

    PubMed  CAS  Google Scholar 

  26. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi:10.1056/NEJMoa043330

    PubMed  CAS  Google Scholar 

  27. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 5:79–88. doi:10.1215/15228517-5-2-79

    PubMed  CAS  Google Scholar 

  28. McDermott MW, Berger MS, Kunwar S, Parsa AT, Sneed PK, Larson DA (2004) Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms. J Neurooncol 69:83–100. doi:10.1023/B:NEON.0000041873.42938.13

    PubMed  CAS  Google Scholar 

  29. Berman JI, Berger MS, Chung SW, Nagarajan SS, Henry RG (2007) Accuracy of diffusion tensor magnetic resonance imaging tractography assessed using intraoperative subcortical stimulation mapping and magnetic source imaging. J Neurosurg 107:488–494. doi:10.3171/JNS-07/09/0488

    PubMed  Google Scholar 

  30. Black PM, Alexander E 3rd, Martin C, Moriarty T, Nabavi A, Wong TZ, Schwartz RB, Jolesz F (1999) Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 45:423–431. doi:10.1097/00006123-199909000-00001 discussion 431–423

    PubMed  CAS  Google Scholar 

  31. Hall WA, Kowalik K, Liu H, Truwit CL, Kucharezyk J (2003) Costs and benefits of intraoperative MR-guided brain tumor resection. Acta Neurochir Suppl (Wien) 85:137–142

    CAS  Google Scholar 

  32. Knierim DS, Yamada S (2003) Pineal tumors and associated lesions: the effect of ethnicity on tumor type and treatment. Pediatr Neurosurg 38:307–323. doi:10.1159/000070415

    PubMed  Google Scholar 

  33. Nomura K (2001) Epidemiology of germ cell tumors in Asia of pineal region tumor. J Neurooncol 54:211–217. doi:10.1023/A:1012771204732

    PubMed  CAS  Google Scholar 

  34. Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16:562–566

    PubMed  CAS  Google Scholar 

  35. McLendon RE, Robinson JS Jr, Chambers DB, Grufferman S, Burger PC (1985) The glioblastoma multiforme in Georgia, 1977–1981. Cancer 56:894–897. doi:10.1002/1097-0142(19850815)56:4<894::AID-CNCR2820560432>3.0.CO;2-#

    PubMed  CAS  Google Scholar 

  36. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20:E1. doi:10.3171/foc.2006.20.4.1

    Article  PubMed  Google Scholar 

  37. Central Brain Tumor Registry of the United States (2008) Statistical report: primary brain tumors in the United States, 2000–2004. CBTRUS, Hinsdale, IL

  38. Claus EB, Black PM (2006) Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973–2001. Cancer 106:1358–1363. doi:10.1002/cncr.21733

    PubMed  Google Scholar 

  39. Preston-Martin S (1989) Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology 8:283–295. doi:10.1159/000110196

    PubMed  CAS  Google Scholar 

  40. Heshmat MY, Kovi J, Simpson C, Kennedy J, Fan KJ (1976) Neoplasms of the central nervous system. Incidence and population selectivity in the Washington DC, metropolitan area. Cancer 38:2135–2142. doi:10.1002/1097-0142(197611)38:5<2135::AID-CNCR2820380543>3.0.CO;2-T

    PubMed  CAS  Google Scholar 

  41. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F (2006) Association of meningioma with reproductive factors. Int J Cancer 119:1152–1157. doi:10.1002/ijc.21950

    PubMed  CAS  Google Scholar 

  42. Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Linet MS (2003) Sociodemographic indicators and risk of brain tumours. Int J Epidemiol 32:225–233. doi:10.1093/ije/dyg051

    PubMed  Google Scholar 

  43. Stangerup SE, Tos M, Caye-Thomasen P, Tos T, Klokker M, Thomsen J (2004) Increasing annual incidence of vestibular schwannoma and age at diagnosis. J Laryngol Otol 118:622–627. doi:10.1258/0022215041917989

    PubMed  Google Scholar 

  44. Schwartz MS, Fisher LM (2006) Incidence and clinical characteristics of acoustic neuroma in Beverly Hills. Skull Base 16(Suppl 1):11–12 abstract

    Google Scholar 

  45. Caban AJ, Lee DJ, Gomez-Marin O, Lam BL, Zheng DD (2005) Prevalence of concurrent hearing and visual impairment in US adults: The National Health Interview Survey, 1997–2002. Am J Public Health 95:1940–1942. doi:10.2105/AJPH.2004.056671

    PubMed  Google Scholar 

  46. Seedat RY, Claassen AJ, Mol DA (2002) Incidence and management of acoustic neuromas in South Africa. Otol Neurotol 23:996–998. doi:10.1097/00129492-200211000-00031

    PubMed  CAS  Google Scholar 

  47. Claasen AJ (1996) Acoustic neuroma surgery in South Africa. 32nd Annual Congress of the South African Society of Otorhinolaryngology Head Neck Surgery, Durban, South Africa

  48. Karami S, Young HA, Henson DE (2007) Earlier age at diagnosis: another dimension in cancer disparity? Cancer Detect Prev 31:29–34. doi:10.1016/j.cdp.2006.11.004

    PubMed  Google Scholar 

  49. Benign Brain Tumor Cancer Registries Amendment Act (2002) Public Law 107–260. http://training.seer.cancer.gov/ss_module00_bbt/unit01_sec02_history_public_law.html

  50. Bamshad M (2005) Genetic influences on health: does race matter? JAMA 294:937–946. doi:10.1001/jama.294.8.937

    PubMed  CAS  Google Scholar 

  51. Chen VW, Fenoglio-Preiser CM, Wu XC, Coates RJ, Reynolds P, Wickerham DL, Andrews P, Hunter C, Stemmermann G, Jackson JS, Edwards BK (1997) Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev 6:1087–1093

    PubMed  CAS  Google Scholar 

  52. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502. doi:10.1001/jama.295.21.2492

    PubMed  CAS  Google Scholar 

  53. Powell IJ (2007) Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 177:444–449. doi:10.1016/j.juro.2006.09.024

    PubMed  Google Scholar 

  54. Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA (2006) Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Res 12:839–844. doi:10.1158/1078-0432.CCR-05-1846

    PubMed  CAS  Google Scholar 

  55. Tang J, Shao W, Dorak MT, Li Y, Miike R, Lobashevsky E, Wiencke JK, Wrensch M, Kaslow RA, Cobbs CS (2005) Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 14:2040–2044. doi:10.1158/1055-9965.EPI-05-0136

    PubMed  CAS  Google Scholar 

  56. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA (2001) Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 62:1009–1030. doi:10.1016/S0198-8859(01)00298-1

    PubMed  CAS  Google Scholar 

  57. Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M (2001) Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res 61:3949–3954

    PubMed  CAS  Google Scholar 

  58. Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M (2005) Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 14:1774–1783. doi:10.1158/1055-9965.EPI-05-0089

    PubMed  CAS  Google Scholar 

  59. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137. doi:10.1056/NEJMsa012337

    PubMed  Google Scholar 

  60. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117–2127. doi:10.1056/NEJMsa035205

    PubMed  CAS  Google Scholar 

  61. Morris AM, Wei Y, Birkmeyer NJ, Birkmeyer JD (2006) Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg 203:787–794. doi:10.1016/j.jamcollsurg.2006.08.005

    PubMed  Google Scholar 

  62. Barker FG 2nd (2004) Craniotomy for the resection of metastatic brain tumors in the U.S. 1988–2000: decreasing mortality and the effect of provider caseload. Cancer 100:999–1007. doi:10.1002/cncr.20058

    PubMed  Google Scholar 

  63. Barker FG 2nd, Carter BS, Ojemann RG, Jyung RW, Poe DS, McKenna MJ (2003) Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope 113:1332–1343. doi:10.1097/00005537-200308000-00013

    PubMed  Google Scholar 

  64. Barker FG 2nd, Curry WT Jr, Carter BS (2005) Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro-oncol 7:49–63. doi:10.1215/S1152851704000146

    PubMed  Google Scholar 

  65. Curry WT, McDermott MW, Carter BS, Barker FG 2nd (2005) Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 102:977–986

    PubMed  Google Scholar 

  66. Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709–4719. doi:10.1210/jc.2003-030461

    PubMed  CAS  Google Scholar 

  67. Cowan JA Jr, Dimick JB, Leveque JC, Thompson BG, Upchurch GR Jr, Hoff JT (2003) The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery 52:48–53. doi:10.1097/00006123-200301000-00005 discussion 53–44

    PubMed  Google Scholar 

  68. Long DM, Gordon T, Bowman H, Etzel A, Burleyson G, Betchen S, Garonzik IM, Brem H (2003) Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery 52:1056–1063. doi:10.1227/01.NEU.0000057745.48813.93. discussion 1063–1065

    PubMed  Google Scholar 

  69. Curry WT, Carter BS, Barker FG (2006) Racial disparities in patient outcomes after craniotomy for tumor in the United States: a population-based analysis. Neurosurgery 57:406 abstract

    Google Scholar 

  70. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan AE (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642–648. doi:10.3171/JNS/2008/108/4/0642

    PubMed  Google Scholar 

  71. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628–634. doi:10.1002/ana.21521

    PubMed  Google Scholar 

  72. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345. doi:10.1200/JCO.2007.13.9337

    PubMed  Google Scholar 

  73. Lucas FL, Stukel TA, Morris AM, Siewers AE, Birkmeyer JD (2006) Race and surgical mortality in the United States. Ann Surg 243:281–286. doi:10.1097/01.sla.0000197560.92456.32

    PubMed  CAS  Google Scholar 

  74. Birkmeyer NJ, Gu N, Baser O, Morris AM, Birkmeyer JD (2008) Socioeconomic status and surgical mortality in the elderly. Med Care 46:893–899. doi:10.1097/MLR.0b013e31817925b0

    PubMed  Google Scholar 

  75. Liu JH, Zingmond DS, McGory ML, SooHoo NF, Ettner SL, Brook RH, Ko CY (2006) Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 296:1973–1980. doi:10.1001/jama.296.16.1973

    PubMed  CAS  Google Scholar 

  76. Quinones-Hinojosa A, Mukherjee D, Chaichana KL, Chang D (2008) National disparities and trends in patients’ access to craniotomies for brain tumor, 2001–2005. [abstract] available at: http://2008cnsorg/AbstractPop2aspx?ID=3262

  77. Quinones-Hinojosa A, Mukherjee D, Chaichana KL, Chang D (2008) National disparities in access to hypophysectomy among pituitary tumor patients, 2001–2005. [abstract] available at: http://2008cnsorg/AbstractPop2aspx?ID=3284

  78. Smith ER, Butler WE, Barker FG 2nd (2004) Craniotomy for resection of pediatric brain tumors in the United States, 1988 to 2000: effects of provider caseloads and progressive centralization and specialization of care. Neurosurgery 54:553–563. doi:10.1227/01.NEU.0000108421.69822.67. discussion 563–565

    PubMed  Google Scholar 

  79. Simpson JR, Scott CB, Rotman M, Curran WJ, Constine LSIII, Fischbach AJ, Asbell SO (1996) Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group. Am J Clin Oncol 19:114–120. doi:10.1097/00000421-199604000-00005

    PubMed  CAS  Google Scholar 

  80. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS (1999) Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382–1390. doi:10.1093/jnci/91.16.1382

    PubMed  CAS  Google Scholar 

  81. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53:5–26. doi:10.3322/canjclin.53.1.5

    PubMed  Google Scholar 

  82. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncol 4:278–299. doi:10.1215/15228517-4-4-278

    PubMed  Google Scholar 

  83. Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 98:603–609. doi:10.1002/cncr.11534

    PubMed  Google Scholar 

  84. Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997. J Neurosurg 99:458–466

    PubMed  Google Scholar 

  85. Ryken TC, Frankel B, Julien T, Olson JJ (2008) Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol 89:271–286. doi:10.1007/s11060-008-9614-5

    PubMed  Google Scholar 

  86. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401. doi:10.1016/S1470-2045(06)70665-9

    PubMed  CAS  Google Scholar 

  87. Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, Lucci A, Green B, Ota D, Nelson H (2006) Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer 106:188–195. doi:10.1002/cncr.21592

    PubMed  Google Scholar 

  88. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328–3334. doi:10.1245/s10434-007-9500-y

    PubMed  Google Scholar 

  89. Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291:2720–2726. doi:10.1001/jama.291.22.2720

    PubMed  CAS  Google Scholar 

  90. Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SA (2004) A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg 199:644–651. doi:10.1016/j.jamcollsurg.2004.05.282

    PubMed  Google Scholar 

  91. Curran WJ Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG et al (1993) Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11:857–862

    PubMed  Google Scholar 

  92. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585–2597. doi:10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S

    PubMed  CAS  Google Scholar 

  93. Junor EJ, Hole DJ, Gillis CR (1994) Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 70:363–370

    PubMed  CAS  Google Scholar 

  94. Braunholtz DA, Edwards SJ, Lilford RJ (2001) Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”. J Clin Epidemiol 54:217–224. doi:10.1016/S0895-4356(00)00305-X

    PubMed  CAS  Google Scholar 

  95. Jones JH (1993) Bad blood: the Tuskegee syphilis experiment. Free Press, New York

    Google Scholar 

  96. McCallum JM, Arekere DM, Green BL, Katz RV, Rivers BM (2006) Awareness and knowledge of the US Public Health Service syphilis study at Tuskegee: implications for biomedical research. J Health Care Poor Underserved 17:716–733. doi:10.1353/hpu.2006.0130

    PubMed  Google Scholar 

  97. Katz RV, Kegeles SS, Kressin NR, Green BL, James SA, Wang MQ, Russell SL, Claudio C (2008) Awareness of the Tuskegee Syphilis Study and the US presidential apology and their influence on minority participation in biomedical research. Am J Public Health 98:1137–1142. doi:10.2105/AJPH.2006.100131

    PubMed  Google Scholar 

  98. Corbie-Smith G, Thomas SB, St George DM (2002) Distrust, race, and research. Arch Intern Med 162:2458–2463. doi:10.1001/archinte.162.21.2458

    PubMed  Google Scholar 

  99. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14:537–546. doi:10.1046/j.1525-1497.1999.07048.x

    PubMed  CAS  Google Scholar 

  100. Chang SM, Barker FG 2nd, Schmidt MH, Sloan AE, Kasper R, Phillips L, Shih K, Hariharan S, Berger MS (2002) Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer 94:2681–2687. doi:10.1002/cncr.10536

    PubMed  Google Scholar 

  101. Barker FG 2nd, Curry WT (2007) Racial and socioeconomic disparities in enrollment in CTEP-sponsored brain tumor therapeutic trials. Neuro-oncol 9:478–479 abstract

    Google Scholar 

  102. Bleyer WA, Tejeda H, Murphy SB, Robison LL, Ross JA, Pollock BH, Severson RK, Brawley OW, Smith MA, Ungerleider RS (1997) National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 21:366–373. doi:10.1016/S1054-139X(97)00110-9

    PubMed  CAS  Google Scholar 

  103. Bleyer WA, Tejeda HA, Murphy SB, Brawley OW, Smith MA, Ungerleider RS (1997) Equal participation of minority patients in U.S. national pediatric cancer clinical trials. J Pediatr Hematol Oncol 19:423–427. doi:10.1097/00043426-199709000-00003

    PubMed  CAS  Google Scholar 

  104. Cooper LA, Beach MC, Johnson RL, Inui TS (2006) Delving below the surface. Understanding how race and ethnicity influence relationships in health care. J Gen Intern Med 21(Suppl 1):S21–S27. doi:10.1111/j.1525-1497.2006.00305.x

    PubMed  Google Scholar 

  105. Kohn LT, Corrigan JM, Donaldson MS (eds) (1999) To err is human: building a safer health system. National Academy Press, Washington

    Google Scholar 

  106. Saha S, Shipman SA (2008) Race-neutral versus race-conscious workforce policy to improve access to care. Health Aff (Millwood) 27:234–245. doi:10.1377/hlthaff.27.1.234

    Google Scholar 

  107. Sarto G (2005) Of disparities and diversity: where are we? Am J Obstet Gynecol 192:1188–1195. doi:10.1016/j.ajog.2004.12.065

    PubMed  Google Scholar 

  108. Komaromy M, Grumbach K, Drake M, Vranizan K, Lurie N, Keane D, Bindman AB (1996) The role of black and Hispanic physicians in providing health care for underserved populations. N Engl J Med 334:1305–1310. doi:10.1056/NEJM199605163342006

    PubMed  CAS  Google Scholar 

  109. Saha S, Komaromy M, Koepsell TD, Bindman AB (1999) Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med 159:997–1004. doi:10.1001/archinte.159.9.997

    PubMed  CAS  Google Scholar 

  110. Saha S, Taggart SH, Komaromy M, Bindman AB (2000) Do patients choose physicians of their own race? Health Aff (Millwood) 19:76–83. doi:10.1377/hlthaff.19.4.76

    CAS  Google Scholar 

  111. Laveist TA, Nuru-Jeter A (2002) Is doctor-patient race concordance associated with greater satisfaction with care? J Health Soc Behav 43:296–306. doi:10.2307/3090205

    PubMed  Google Scholar 

  112. Cantor JC, Miles EL, Baker LC, Barker DC (1996) Physician service to the underserved: implications for affirmative action in medical education. Inquiry 33:167–180

    PubMed  CAS  Google Scholar 

  113. Xu G, Fields SK, Laine C, Veloski JJ, Barzansky B, Martini CJ (1997) The relationship between the race/ethnicity of generalist physicians and their care for underserved populations. Am J Public Health 87:817–822. doi:10.2105/AJPH.87.5.817

    PubMed  CAS  Google Scholar 

  114. Newman LA, Pollock RE, Johnson-Thompson MC (2003) Increasing the pool of academically oriented African-American medical and surgical oncologists. Cancer 97:329–334. doi:10.1002/cncr.11027

    PubMed  Google Scholar 

  115. Andriole DA, Jeffe DB, Schechtman KB (2007) Is surgical workforce diversity increasing? J Am Coll Surg 204:469–477. doi:10.1016/j.jamcollsurg.2006.12.035

    PubMed  Google Scholar 

  116. Butler PD, Longaker MT, Britt LD (2008) Major deficit in the number of underrepresented minority academic surgeons persists. Ann Surg 248:704–711. doi:10.1097/SLA.0b013e31817f2c30

    PubMed  Google Scholar 

  117. Nunez-Smith M, Curry LA, Bigby J, Berg D, Krumholz HM, Bradley EH (2007) Impact of race on the professional lives of physicians of African descent. Ann Intern Med 146:45–51

    PubMed  Google Scholar 

  118. Fisher TL, Burnet DL, Huang ES, Chin MH, Cagney KA (2007) Cultural leverage: interventions using culture to narrow racial disparities in health care. Med Care Res Rev 64:243S–282S. doi:10.1177/1077558707305414

    PubMed  Google Scholar 

  119. Smedley BD, Stith AY, Colburn L, Evans CH (eds) (2001) The right thing to do, the smart thing to do: enhancing diversity in the health professions. National Academy Press, Washington

    Google Scholar 

  120. Smedley BD, Butler AS, Bristow LR (eds) (2004) In The Nation’s Compelling Interest: ensuring diversity in the health-care workforce. National Academies Press, Washington

    Google Scholar 

  121. Steinberg ML (2008) Inequity in cancer care: explanations and solutions for disparity. Semin Radiat Oncol 18:161–167. doi:10.1016/j.semradonc.2008.01.003

    PubMed  Google Scholar 

  122. Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE Jr (2006) Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer 107:2669–2677. doi:10.1002/cncr.22319

    PubMed  Google Scholar 

  123. Steinberg ML, Knapp H, Khan DC, Kwon R, Streeter O, Forge N, Fremont A (2007) Patient-centered satisfaction and well-being assessment in a lay patient navigator program for underserved populations. Int J Radiat Oncol Biol Phys 69:S563–S564. doi:10.1016/j.ijrobp.2007.07.1829

    Google Scholar 

  124. Newman LA, Roff NK, Weinberg AD (2008) Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all. Ann Surg Oncol 15:1818–1819. doi:10.1245/s10434-008-9869-2

    PubMed  Google Scholar 

  125. Pulido JS, Vierkant RA, Olson JE, Abrey L, Schiff D, O’Neill BP (2008) Racial differences in PCNSL incidence and survival. Ann Neurol 64(Suppl 12):S61 abstract

    Google Scholar 

  126. Propp JM, McCarthy BJ, Davis FG, Preston-Martin S (2006) Descriptive epidemiology of vestibular schwannomas. Neuro-oncol 8:1–11. doi:10.1215/S1522851704001097

    PubMed  Google Scholar 

  127. Barnholtz-Sloan JS, Maldonado JL, Williams VL, Curry WT, Rodkey EA, Barker FG 2nd, Sloan AE (2007) Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol 85:171–180. doi:10.1007/s11060-007-9405-4

    PubMed  Google Scholar 

  128. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER Jr (1998) Factors associated with survival in patients with meningioma. J Neurosurg 88:831–839

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery (Neurosurgery), Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Yawkey 9E, Fruit Street, Boston, MA, 02114, USA

    William T. Curry Jr. & Fred G. Barker II

Authors
  1. William T. Curry Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fred G. Barker II
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William T. Curry Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Curry, W.T., Barker, F.G. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol 93, 25–39 (2009). https://doi.org/10.1007/s11060-009-9840-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-9840-5

Keywords

Search

Navigation